These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 26093618)

  • 1. Heat shock protein vaccines against glioblastoma: from bench to bedside.
    Ampie L; Choy W; Lamano JB; Fakurnejad S; Bloch O; Parsa AT
    J Neurooncol; 2015 Jul; 123(3):441-8. PubMed ID: 26093618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat-shock proteins-based immunotherapy for advanced melanoma in the era of target therapies and immunomodulating agents.
    Tosti G; Cocorocchio E; Pennacchioli E; Ferrucci PF; Testori A; Martinoli C
    Expert Opin Biol Ther; 2014 Jul; 14(7):955-67. PubMed ID: 24670226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat shock proteins in glioblastomas.
    Yang I; Fang S; Parsa AT
    Neurosurg Clin N Am; 2010 Jan; 21(1):111-23. PubMed ID: 19944971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat-shock protein vaccines as active immunotherapy against human gliomas.
    Yang I; Han S; Parsa AT
    Expert Rev Anticancer Ther; 2009 Nov; 9(11):1577-82. PubMed ID: 19895242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promising vaccines for treating glioblastoma.
    Swartz AM; Shen SH; Salgado MA; Congdon KL; Sanchez-Perez L
    Expert Opin Biol Ther; 2018 Nov; 18(11):1159-1170. PubMed ID: 30281978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Immunotherapy for Glioblastoma Multiforme.
    Huang B; Zhang H; Gu L; Ye B; Jian Z; Stary C; Xiong X
    J Immunol Res; 2017; 2017():3597613. PubMed ID: 28299344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat shock protein-peptide complex in the treatment of glioblastoma.
    See AP; Pradilla G; Yang I; Han S; Parsa AT; Lim M
    Expert Rev Vaccines; 2011 Jun; 10(6):721-31. PubMed ID: 21692695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cell immunotherapy for glioblastoma.
    Polyzoidis S; Ashkan K
    Expert Rev Anticancer Ther; 2014 Jul; 14(7):761-3. PubMed ID: 24850137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What's next in glioblastoma treatment: Tumor-targeted or immune-targeted therapies?].
    Schernberg A; Marabelle A; Massard C; Armand JP; Dumont S; Deutsch E; Dhermain F
    Bull Cancer; 2016 May; 103(5):484-98. PubMed ID: 27032303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine therapies for patients with glioblastoma.
    Sayegh ET; Oh T; Fakurnejad S; Bloch O; Parsa AT
    J Neurooncol; 2014 Sep; 119(3):531-46. PubMed ID: 25163836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual patient-specific immunity against high-grade glioma after vaccination with autologous tumor derived peptides bound to the 96 KD chaperone protein.
    Crane CA; Han SJ; Ahn B; Oehlke J; Kivett V; Fedoroff A; Butowski N; Chang SM; Clarke J; Berger MS; McDermott MW; Prados MD; Parsa AT
    Clin Cancer Res; 2013 Jan; 19(1):205-14. PubMed ID: 22872572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Immunotherapeutics for Treatment of Glioblastoma: The Last Decade of Research.
    Khansur E; Shah AH; Lacy K; Komotar RJ
    Cancer Invest; 2019; 37(1):1-7. PubMed ID: 30632816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock protein peptide complex-96 vaccination for newly diagnosed glioblastoma: a phase I, single-arm trial.
    Ji N; Zhang Y; Liu Y; Xie J; Wang Y; Hao S; Gao Z
    JCI Insight; 2018 May; 3(10):. PubMed ID: 29769450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine-based immunotherapy for glioblastoma.
    Thomas AA; Fisher JL; Ernstoff MS; Fadul CE
    CNS Oncol; 2013 Jul; 2(4):331-49. PubMed ID: 25054578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma.
    Batich KA; Swartz AM; Sampson JH
    Expert Opin Biol Ther; 2015 Jan; 15(1):79-94. PubMed ID: 25327832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [II. Autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma].
    Maruyama T; Muragaki Y; Ishikawa E; Nitta M; Saito T; Ohno T; Iseki H; Okada Y
    Gan To Kagaku Ryoho; 2015 Jun; 42(6):683-6. PubMed ID: 26242005
    [No Abstract]   [Full Text] [Related]  

  • 17. Heat shock protein-based cancer vaccines.
    Oki Y; Younes A
    Expert Rev Vaccines; 2004 Aug; 3(4):403-11. PubMed ID: 15270645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current challenges in designing GBM trials for immunotherapy.
    Weathers SP; Gilbert MR
    J Neurooncol; 2015 Jul; 123(3):331-7. PubMed ID: 25577401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine strategies for glioblastoma: progress and future directions.
    Jackson C; Ruzevick J; Brem H; Lim M
    Immunotherapy; 2013 Feb; 5(2):155-67. PubMed ID: 23413907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulation for glioblastoma.
    Reardon DA; Wen PY; Wucherpfennig KW; Sampson JH
    Curr Opin Neurol; 2017 Jun; 30(3):361-369. PubMed ID: 28368867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.